Author

Sarb Shergill

Observed name: S. Shergill

Institution: Dicerna Pharmaceuticals (United States)

Observed institution: Dicerna Pharmaceuticals (United States)

OpenAlex ID: A5087948980

Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials

2021 · Joan B Mannick, Grace Teo, et al. · The Lancet Healthy Longevity · 136

LB2. TORC1 Inhibition with RTB101 as a Potential Pan-Antiviral Immunotherapy to Decrease the Incidence of Respiratory Tract Infections Due to Multiple Respiratory Viruses in Older Adults

2019 · Joan Mannick, Amelia Tomlinson, et al. · Open Forum Infectious Diseases · 2

Oral TORC1 Inhibitor Dactolisib Enhances Immune Function and Reduces the Incidence of Respiratory Tract Infections in Elderly Subjects with Asthma

2019 · J. Mannick, S. Shergill, et al. · American Journal of Respiratory and Critical Care Medicine

Works count: 3

Citation count: 138

H-index: 2

I10-index: 1